These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 15351206)
1. Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase. Fotheringham J; Mayne M; Holden C; Nath A; Geiger JD Virology; 2004 Oct; 327(2):186-95. PubMed ID: 15351206 [TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 Tat protein induces an intracellular calcium increase in human monocytes that requires DHP receptors: involvement in TNF-alpha production. Contreras X; Bennasser Y; Chazal N; Moreau M; Leclerc C; Tkaczuk J; Bahraoui E Virology; 2005 Feb; 332(1):316-28. PubMed ID: 15661163 [TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes. Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243 [TBL] [Abstract][Full Text] [Related]
4. The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. Bshesh K; Zhao B; Spight D; Biaggioni I; Feokistov I; Denenberg A; Wong HR; Shanley TP J Leukoc Biol; 2002 Nov; 72(5):1027-36. PubMed ID: 12429726 [TBL] [Abstract][Full Text] [Related]
5. Activation of adenosine receptors inhibits tumor necrosis factor-alpha release by decreasing TNF-alpha mRNA stability and p38 activity. Fotheringham JA; Mayne MB; Grant JA; Geiger JD Eur J Pharmacol; 2004 Aug; 497(1):87-95. PubMed ID: 15321739 [TBL] [Abstract][Full Text] [Related]
6. Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene. Pocsik E; Higuchi M; Aggarwal BB Lymphokine Cytokine Res; 1992 Dec; 11(6):317-25. PubMed ID: 1335762 [TBL] [Abstract][Full Text] [Related]
7. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. Lafrenie RM; Wahl LM; Epstein JS; Yamada KM; Dhawan S J Immunol; 1997 Oct; 159(8):4077-83. PubMed ID: 9378998 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy. Matzen K; Dirkx AE; oude Egbrink MG; Speth C; Götte M; Ascherl G; Grimm T; Griffioen AW; Stürzl M Virus Res; 2004 Sep; 104(2):145-55. PubMed ID: 15246652 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells. Caldwell RL; Gadipatti R; Lane KB; Shepherd VL J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533 [TBL] [Abstract][Full Text] [Related]
10. [HIV-1 Tat induces TNF-alpha production by human monocytes: involvement of calcium and PKC pathways]. Contreras X; Bennasser Y; Chazal N; Bahraoui E J Soc Biol; 2003; 197(3):267-75. PubMed ID: 14708348 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha stimulates HIV-1 production in primary culture of human adipocytes. Maurin T; Saillan-Barreau C; Cousin B; Casteilla L; Doglio A; Pénicaud L Exp Cell Res; 2005 Apr; 304(2):544-51. PubMed ID: 15748898 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 Tat dysregulation of lipopolysaccharide-induced cytokine responses: microbial interactions in HIV infection. Yim HC; Li JC; Lau JS; Lau AS AIDS; 2009 Jul; 23(12):1473-84. PubMed ID: 19622906 [TBL] [Abstract][Full Text] [Related]
13. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein. Hui B; Xia W; Li J; Wang L; Ai J; Geng M J Neurochem; 2006 Apr; 97(2):334-44. PubMed ID: 16539678 [TBL] [Abstract][Full Text] [Related]
14. [HIV-1 Tat protein induces IL-10 production by human monocytes: implications of the PKC and calcium pathway]. Bennasser Y; Contreras X; Moreau M; Le Clerc C; Badou A; Bahraoui E J Soc Biol; 2001; 195(3):319-26. PubMed ID: 11833470 [TBL] [Abstract][Full Text] [Related]
15. Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. Martin L; Pingle SC; Hallam DM; Rybak LP; Ramkumar V J Pharmacol Exp Ther; 2006 Jan; 316(1):71-8. PubMed ID: 16188954 [TBL] [Abstract][Full Text] [Related]
16. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. Lafrenie RM; Wahl LM; Epstein JS; Hewlett IK; Yamada KM; Dhawan S J Immunol; 1996 Feb; 156(4):1638-45. PubMed ID: 8568270 [TBL] [Abstract][Full Text] [Related]
17. HIV-1 Tat protein induces IL-10 production by an alternative TNF-alpha-independent pathway in monocytes: role of PKC-delta and p38 MAP kinase. Leghmari K; Bennasser Y; Tkaczuk J; Bahraoui E Cell Immunol; 2008; 253(1-2):45-53. PubMed ID: 18541226 [TBL] [Abstract][Full Text] [Related]
18. The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes. Zhang JG; Hepburn L; Cruz G; Borman RA; Clark KL Biochem Pharmacol; 2005 Mar; 69(6):883-9. PubMed ID: 15748700 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide. Fortin A; Harbour D; Fernandes M; Borgeat P; Bourgoin S J Leukoc Biol; 2006 Mar; 79(3):574-85. PubMed ID: 16387843 [TBL] [Abstract][Full Text] [Related]
20. Interactions of the HIV-1 Tat and RAP74 proteins with the RNA polymerase II CTD phosphatase FCP1. Abbott KL; Archambault J; Xiao H; Nguyen BD; Roeder RG; Greenblatt J; Omichinski JG; Legault P Biochemistry; 2005 Mar; 44(8):2716-31. PubMed ID: 15723517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]